LncRNA WISP1-AS破坏WISP1mRNA和蛋白一致性在肝癌细胞增殖中作用及机制研究

批准号:
81960443
项目类别:
地区科学基金项目
资助金额:
34.0 万元
负责人:
阎金龙
依托单位:
学科分类:
肿瘤细胞命运
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
阎金龙
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
微信扫码咨询
中文摘要
我们研究发现肝癌中WISP1mRNA高表达而蛋白低表达,其mRNA和蛋白表达显著不一致[2018,hepatology],这种现象可能与mRNA翻译异常有关。然而,WISP1mRNA翻译异常是否与其不一致性有关仍不清楚。研究显示LncRNA可调控mRNA翻译。前期RNA-Seq发现: 肝癌中LncRNA-WISP1-AS(WISP1-AS)高表达;下调WISP1-AS表达导致WISP1蛋白表达增加,而mRNA表达不变,其mRNA和蛋白不一致程度下降,且抑制肝癌细胞增殖;下调WISP1-AS表达同时干扰WISP1表达回复了肝癌细胞增殖;生物软件预测WISP1-AS可与WISP1mRNA结合。据此推测:WISP1-AS破坏WISP1mRNA和蛋白一致性促进肝癌细胞增殖。为验证推测,本课题拟明确WISP1-AS破坏WISP1mRNA和蛋白一致性机制,为肝癌防治提供新的理论依据。
英文摘要
We have found that WISP1 mRNA is highly expressed and WISP1 protein low expressed in hepatocellular carcinoma. The WISP1 WISP1 mRNA and protein expression is significantly discordant. [2018, hepatology]. This phenomenon may be related to abnormal translation of WISP1 mRNA. However, it is not clear whether the abnormal translation of WISP1 is related to its discordance. Studies have shown that LncRNA can regulate the translation of mRNA. Previous findings in RNA-Seq: high expression of LncRNA-WISP1-AS (WISP1-AS) in hepatocellular carcinoma; Down-regulation of WISP1-AS resulted in increased expression of WISP1 protein , while the expression of WISP1-AS remained unchanged, the degree of discordance between WISP1mRNA and protein decreased, and inhibited the proliferation of hepatocellular carcinoma cells; Interfering WISP1 expression also to restored the proliferation of hepatocellular carcinoma cells with down-regulation of WISP1-AS expression; Biosoftware predicted that WISP1-AS could bind WISP1-AS. It is speculated that WISP1-AS can destroy the accordance of WISP1 mRNA and protein and promote the proliferation of hepatocellular carcinoma cells. In order to verify the hypothesis, we intend to clarify the mechanism of WISP1-AS destroying the accordance of WISP1 mRNA and protein, which provides a new theoretical basis for the prevention and treatment of hepatocellular carcinoma.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI:10.1111/cbdd.14063
发表时间:2022-05
期刊:Chemical Biology & Drug Design
影响因子:3
作者:Minghua Wen;Hongyan Xu;Hong-Qi Peng;Yanling Sheng;Wenlong Yang;Jinlong Yan
通讯作者:Minghua Wen;Hongyan Xu;Hong-Qi Peng;Yanling Sheng;Wenlong Yang;Jinlong Yan
Hepatitis B virus induces sorafenib resistance in liver cancer via upregulation of cIAP2 expression.
DOI:10.1186/s13027-021-00359-2
发表时间:2021-03-23
期刊:Infectious agents and cancer
影响因子:3.7
作者:Zhang S;Li N;Sheng Y;Chen W;Ma Q;Yu X;Lian J;Zeng J;Yang Y;Yan J
通讯作者:Yan J
DOI:10.1016/j.yexcr.2021.112646
发表时间:2021-06-11
期刊:EXPERIMENTAL CELL RESEARCH
影响因子:3.7
作者:Qiu, Yumin;Huang, Dan;Yan, Jinlong
通讯作者:Yan, Jinlong
DOI:10.1186/s13027-023-00502-1
发表时间:2023-04-20
期刊:INFECTIOUS AGENTS AND CANCER
影响因子:3.7
作者:Zeng, Jindi;Wu, Jiancheng;Pang, Shuijiao;Wang, Feifei;Yu, Xin;Zhang, Shouhua;Zeng, Junquan;Yan, Jinlong;Lian, Jianping
通讯作者:Lian, Jianping
DOI:10.1155/2021/3771990
发表时间:2021
期刊:Disease markers
影响因子:--
作者:Li N;Wu L;Zuo X;Luo H;Sheng Y;Yan J
通讯作者:Yan J
高静水压调控USP1/TGF-β正反馈通路对肝癌细胞EMT的作用及机制研究
- 批准号:82260570
- 项目类别:地区科学基金项目
- 资助金额:34万元
- 批准年份:2022
- 负责人:阎金龙
- 依托单位:
国内基金
海外基金
